Skip to main content

2020 | OriginalPaper | Buchkapitel

17. R&D Management in Rare Disease Focused Biotechnology Companies: The Case of Shire

verfasst von : Amir Shaygan, Tania Lilja, Bobby Romanski, Rasnia Tabpla, John Bauer, Hussain Almohameed, Tugrul U. Daim

Erschienen in: Innovation Management in the Intelligent World

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Shire is a 30-year-old global biotechnology company focused on treating rare diseases and other highly specialized conditions, currently underserved by pharmaceutical research and development. The company’s portfolio of pharmaceutical therapies is available across hematology, immunology, neuroscience, lysosomal storage disorders, gastrointestinal disorders, internal medicine, endocrine, and hereditary angioedema in more than 100 countries. Additionally, Shire is growing its therapies used in oncology and ophthalmic. Within these core areas Shire has developed some of its most successful therapies, including Vyvanse used in the treatment of attention deficit hyperactivity disorder (ADHD), Lialda used to treat inflammatory bowel disease, and Adderall XR, also for the treatment of ADHD and narcolepsy (Ornskov 2016).
The case study identifies and analyzes Shire’s approach to R&D management. This research attempts to review the approaches taken and the efficacy of strategic frameworks used within Shire’s product portfolio.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Ahn MJ et al (2009) Death of distance? Biotechnology agglomeration patterns, alliance proximity, and firm performance. Int J Innov Technol Manag 6(03):247–264CrossRef Ahn MJ et al (2009) Death of distance? Biotechnology agglomeration patterns, alliance proximity, and firm performance. Int J Innov Technol Manag 6(03):247–264CrossRef
Zurück zum Zitat Cormican K, O’Connor M (2009) Technology transfer for product life cycle extension: a model for successful implementation. Int J Innov Technol Manag 6(03):265–282CrossRef Cormican K, O’Connor M (2009) Technology transfer for product life cycle extension: a model for successful implementation. Int J Innov Technol Manag 6(03):265–282CrossRef
Zurück zum Zitat Eisenhardt KM, Martin JA (2000) Dynamic capabilities: what are they? Strateg Manag J 21(10–11):1105–1121CrossRef Eisenhardt KM, Martin JA (2000) Dynamic capabilities: what are they? Strateg Manag J 21(10–11):1105–1121CrossRef
Zurück zum Zitat Kaiser L (2010) Management of intellectual property in research and development: a search for systems from the viewpoint of research and technology organizations. Int J Innov Technol Manag 7(3):263–272CrossRef Kaiser L (2010) Management of intellectual property in research and development: a search for systems from the viewpoint of research and technology organizations. Int J Innov Technol Manag 7(3):263–272CrossRef
Zurück zum Zitat Paul SM et al (2010) How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9(3):203–214CrossRef Paul SM et al (2010) How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9(3):203–214CrossRef
Zurück zum Zitat Shire (2015) Shaping what’s next. Shire’s Annual Report Shire (2015) Shaping what’s next. Shire’s Annual Report
Zurück zum Zitat Tsai K-H, Hsieh M-H, Hultink EJ (2011) External technology acquisition and product innovativeness: The moderating roles of R&D investment and configurational context. J Eng Technol Manag 28(3):184–200CrossRef Tsai K-H, Hsieh M-H, Hultink EJ (2011) External technology acquisition and product innovativeness: The moderating roles of R&D investment and configurational context. J Eng Technol Manag 28(3):184–200CrossRef
Zurück zum Zitat Zahra SA, Sapienza HJ, Davidsson P (2006) Entrepreneurship and dynamic capabilities: a review, model and research agenda. J Manag Stud 43(4):917–955CrossRef Zahra SA, Sapienza HJ, Davidsson P (2006) Entrepreneurship and dynamic capabilities: a review, model and research agenda. J Manag Stud 43(4):917–955CrossRef
Metadaten
Titel
R&D Management in Rare Disease Focused Biotechnology Companies: The Case of Shire
verfasst von
Amir Shaygan
Tania Lilja
Bobby Romanski
Rasnia Tabpla
John Bauer
Hussain Almohameed
Tugrul U. Daim
Copyright-Jahr
2020
Verlag
Springer International Publishing
DOI
https://doi.org/10.1007/978-3-030-58301-9_17

Premium Partner